dx.doi.org/10.1093/annonc/mdy270.184, hdl.handle.net/1765/125530
Annals of Oncology
Erasmus MC Cancer Institute

Steenbruggen, T.G. (T. G.), Steggink, L.C. (L. C.), Seynaeve, C.M, van der Hoeven, J, Hooning, M.J. (M. J.), Jager, A, … Gietema, J.A. (2018). High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study. Annals of Oncology, 29. doi:10.1093/annonc/mdy270.184